COVID-19 Vaccines Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2026
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
COVID-19 Vaccines Market Report Overview
The sales of COVID-19 vaccines across the 7MM reached $25 billion in 2021 and consisted of Tour authorized products: Comirnaty, Spikevax, Vaxzevria, and Jcovden. the COVID-19 vaccines market declined across the 7MM in 2022 as most individuals completed primary vaccinations and received at least one dose of an updated bivalent mRNA booster vaccine. Overall, the COVID-19 vaccines market is expected to significantly decline across the 7MM during the forecast period, at a negative compound annual growth rate (CAGR) of 14.5% during 2021 – 2026.
COVID-19 Vaccines Market Outlook, 2021-2026 ($ Billion)
Buy the Report to Get Full Access to the COVID-19 Vaccines Market Forecast or Download a Free Report Sample
The COVID-19 Vaccines market research report provides a forecast model for the COVID-19 Vaccines market through 2026 as well as an overview of the disease, including epidemiology, symptoms, diagnosis, and disease management.
Market Size (2022) | $25 billion |
CAGR (2022 – 2032) | <(14)% |
Forecast Period | 2021-2026 |
Key Countries | · The US
· France · Germany · Italy · Spain · The UK · Japan |
Leading Players | · Comirnaty (tozinameran/BNT162b2)
· Jcovden (Ad26.COV2.S) · Vaxzevria (AZD-1222) · Nuvaxovid (NVX-CoV2373) · VLA-2001 · VidPrevtyn Beta (SP-0253) |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
COVID-19 Vaccines Market Dynamics
The sales of COVID-19 vaccines is forecast to peak in 2023 due to the launch of further updated vaccines by Moderna, Pfizer/BioNTech, and Novavax, which target the currently dominant Omicron XBB.1.5 variant. On the other hand, in 2026, sales of COVID-19 vaccines across the 7MM are forecast to decrease as the pandemic winds down and the need for annual vaccinations and/or boosters becomes less urgent.
Buy the Report to Get Full Access to the COVID-19 Vaccines Market Dynamics or Download a Free Sample Report
COVID-19 Vaccines Market Segmentation by Countries
Some of the key countries in the COVID-19 vaccines market are the US, France, Germany, Italy, Spain, the UK, and Japan. The US represented the largest COVID-19 vaccine market in 2021, followed by Japan. These countries are expected to continue leading the market in 2026.
In 2023, primary course vaccination coverage is expected to be the highest in Italy, while it is forecast to be the lowest in the UK.
COVID-19 Vaccines Market Analysis by Countries, 2023 (%)
Buy the Report to Get Full Access to the country insights of the COVID-19 Vaccines market, Download a Free Sample Report
COVID-19 Vaccines Market - Competitive Landscape
Some of the key players in the COVID-19 vaccines market are Comirnaty (tozinameran/BNT162b2), Jcovden (Ad26.COV2.S), Vaxzevria (AZD-1222), Nuvaxovid (NVX-CoV2373), VLA-2001, VidPrevtyn Beta (SP-0253) among others. Comirnaty (tozinameran/BNT162b2) is the first COVID-19 vaccine and mRNA-based vaccine to gain authorization for use worldwide, leading to a significant first-mover advantage.
Segments Covered in the Report
COVID-19 Vaccines Country Outlook (Value, $ Billion, 2021-2026)
- The US
- France
- Germany
- Italy
- Spain
- The UK
- Japan
Scope
This report provides:
- Overview of Coronavirus disease 2019 (COVID-19) including classification of SARS-CoV-2, etiology, pathophysiology, and epidemiology of COVID-19
- Timeline of COVID-19 outbreak and vaccine development.
- Current treatment options including product profiles for COVID-19 vaccines authorized in the 7MM.
- Analysis of unmet needs and R&A strategies within the COVID-19 market.
- Pipeline analysis including product profiles for leading vaccine candidates in the 7MM.
- COVID-19 vaccines market outlook including revenue breakdown by market, vaccine type, and leading vaccine products from 2021-2026.
Key Highlights
• Report deliverables include a Pdf and an Excel-based forecast model
• Forecast includes the 7 major markets (7MM)
• Forecast covers the period 2021-2026
Reasons to Buy
The report will enable you to:
- Understand the trends shaping and driving the COVID-19 vaccines market.
- Identify the innovative technologies and key players leading the COVID-19 vaccines field.
- Recognize gaps and areas of unmet need within the COVID-19 vaccines market.
- Determine the current and future outlook for COVID-19 vaccines according to key opinion leaders (KOLs).
- Track COVID-19 vaccine sales from 2021-2026.
Pfizer Inc
BioNTech SE
Moderna
Vaxxinity Inc
Arcturus Therapeutics
Bavarian Nordic AS
Johnson & Johnson
AstraZeneca
Sanofi
GlaxoSmithKline AG
Laboratorios Hipra SA
Valneva SE
SK Bioscience Ltd
Daiichi Sankyo Co Ltd
Takeda AS
Shionogi & Co Ltd
Inovio Pharmaceuticals Inc
Table of Contents
Frequently asked questions
-
What was the COVID-19 vaccines market size across the 7MM in 2021?
The COVID-19 vaccines market size across the 7MM was valued at $25 billion in 2021.
-
Which country had the highest share in the 7MM COVID-19 Vaccines market?
The US represented the largest COVID-19 vaccine market in 2021, followed by Japan.
-
Who are the leading players operating in the COVID-19 vaccines market?
Comirnaty (tozinameran/BNT162b2), Jcovden (Ad26.COV2.S), Vaxzevria (AZD-1222), Nuvaxovid (NVX-CoV2373), and VLA-2001.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Vaccine reports

